An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02053624
Contributor : Lauriane Pillet <>
Submitted on : Friday, March 1, 2019 - 2:33:31 PM
Last modification on : Tuesday, October 1, 2019 - 1:25:34 AM

Links full text

Identifiers

Citation

Julien Péron, Pascal Roy, T. Conroy, F. Desseigne, M. Ychou, et al.. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget, Impact journals, 2016, 7, pp.82953-28960. ⟨10.18632/oncotarget.12761⟩. ⟨hal-02053624⟩

Share

Metrics

Record views

21